STING1 and COVID-19: We suggested that type I Interferon and Interferon stimulated genes (ISGs) play protective roles in SARS-CoV-2 infection and indicate that both severe COVID-19 patient groups with/without detectable plasma viral loads are accompanied by a lower type I interferon response in addition to a higher inflammatory response.